ARTG 407533CT contrast medium injection system, line-powered, mobile
ARTG ID: 407533 · Imaxeon Pty Ltd · Bayer Medical Care Inc · Class IIb · Started April 12, 2023
Good Name: Imaxeon Pty Ltd - CT contrast medium injection system, line-powered, mobile
- Risk Class
- Class IIb
- Product Type
- Single Device Product
- ARTG Category
- General
- ARTG ID
- 407533
- Start Date
- April 12, 2023
- Effective Date
- April 12, 2023
- Name
- Imaxeon Pty Ltd
- Country
- United States of America
- Address
- 1 Bayer Drive, Indianola, PA, 15051-0780
The device is intended to provide powered injection of imaging agents (saline, contrast media) in radiological diagnostic procedures.
Access comprehensive regulatory information for CT contrast medium injection system, line-powered, mobile in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is registered under ARTG number 407533 and sponsored by Imaxeon Pty Ltd, manufactured by Bayer Medical Care Inc in United States of America. The device registration started on April 12, 2023.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.